Solutions to drive advances in diverse fields, from cancer research to microbiology, genetic disease, and beyond
Solutions that enable researchers to identify genomic changes in cancer, including somatic variants, gene fusions, epigenetic alterations, and more.
Genetic and rare disease products
Sequencing and microarray kits to advance breakthroughs in rare and genetic disease applications.
Solutions to help labs characterize infectious agents, examine microbial functions, track genetic changes, analyze outbreaks, and more.
Genomic solutions to deliver fast, accurate information that can help guide reproductive health research and inform clinical decision-making.
Complex disease research products
Sequencing and microarray kits for research in immunology, neuroscience, and much more.
Sequencing kits and genotyping arrays for researching a broad range of plant and animal species.
Drug discovery and development products
Genomic variation analysis products to inform drug target discovery, validation, and development.
No matter your area of focus, Illumina helps you unlock possibilities. Illumina technology has powered advances in cancer research, microbiology, infectious diseases, reproductive health, complex diseases, pharmacogenomics, genetic disease testing, and more.
These sequencing systems offer expansive application breadth, operational simplicity, high flexibility and scalability, and proven performance.
Reagents for the NextSeq 1000/2000 System feature easy-to-use cartridges and multiple flow cell configurations for flexible sequencing options.
An efficient, fast, and integrated library preparation workflow that yields highly accurate data for sensitive sequencing applications.
Maximize genomic insights with DRAGEN secondary analysis, learn about the latest updates, read FAQs, and find product support.
Reach out for information about our products and services or get answers to questions about our technology or applications.
Your email address is never shared with third parties.